U.S. Insurance Stock News

In January 2026, Vertiv launched Vertiv Next Predict, an AI-powered managed service that uses predictive analytics and anomaly detection to transform data center maintenance across power, cooling, and IT systems. This move deepens Vertiv’s role at the heart of AI data center infrastructure by tying its service expertise to a scalable, grid-to-chip AI operations platform designed to evolve with future technologies. We’ll now examine how this AI-driven maintenance offering could shape...

Vistra (NYSE:VST) has closed a $2.25b private offering to fund its acquisition of Cogentrix Energy. The deal adds 10 natural gas fired power plants and 5,500 megawatts of generation capacity to Vistra's portfolio. The transaction expands Vistra's power generation footprint and materially increases its operational scale. For investors watching Vistra at a share price of $142.52, this Cogentrix move comes during a period of mixed recent returns. The stock has seen a 14.0% decline over the...

If you are wondering whether C.H. Robinson Worldwide is priced attractively after a strong run, this article walks through what the current share price might be implying about its underlying value. The stock last closed at US$198.74, with returns of 7.8% over 7 days, 18.9% over 30 days, 21.4% year to date, 108.8% over 1 year, 107.2% over 3 years, and 146.0% over 5 years. This naturally raises questions about what is already priced in. Recent coverage has focused on how the company fits into...

AvePoint recently introduced new agentic AI governance tools and expanded multi-SaaS, IaaS, and PaaS data protection capabilities for its Confidence Platform, giving organizations deeper visibility and control over AI-related data risks. By allowing enterprises to define and monitor AI agent risk according to their own policies and remediate issues directly in the platform, AvePoint is positioning its offering squarely at the data quality and security challenges that cause most agentic AI...

In recent sessions, ADMA Biologics reported growing analyst optimism ahead of its upcoming earnings release, supported by positive revisions to earnings estimates and recognition of its specialty focus in plasma-derived biologics for immune deficiencies and infectious diseases. An interesting angle is ADMA’s integrated plasma collection and production model, which analysts view as central to its differentiation in the biologics market. Next, we’ll explore how this rising analyst confidence...

FIGS has recently launched a Winter Olympics campaign featuring Lindsey Vonn, extending its partnership with the USOPC and outfitting Team USA’s medical team, while selling a limited-edition FIGS x Team USA collection online and in stores. By spotlighting the healthcare professionals behind an elite athlete’s comeback, FIGS is tightly aligning its brand with high-performance medicine and national pride. We’ll now examine how this high-profile Lindsey Vonn and Team USA medical team campaign...

As the United States stock market begins February on a high note, with major indices like the Dow Jones and S&P 500 showing significant gains, investors are closely monitoring opportunities amidst fluctuating economic indicators. In this environment of heightened market activity and shifting economic policies, identifying undervalued stocks can be crucial for those looking to capitalize on potential discounts in the market.

As February 2026 begins, the U.S. stock market has shown strength with major indices like the Dow Jones and S&P 500 posting significant gains, buoyed by positive economic indicators such as an unexpected expansion in manufacturing activity. In this environment of heightened market optimism, identifying high-growth tech stocks involves focusing on companies that demonstrate robust innovation and adaptability to capitalize on emerging trends and technological advancements.

As February 2026 begins, U.S. stock indexes have shown a strong start with the Dow climbing 515 points and the S&P 500 nearing record highs, reflecting a positive sentiment in the market despite ongoing economic uncertainties such as delayed jobs reports and geopolitical tensions. In this environment of fluctuating indices and evolving trade dynamics, growth companies with high insider ownership can present intriguing opportunities for investors seeking robust revenue expansion, as these...

As February begins, the U.S. stock market has shown a robust start with major indexes like the Dow Jones Industrial Average and S&P 500 ending sharply higher. For those looking to invest in smaller or newer companies, penny stocks—despite their name's vintage feel—can still offer surprising value. This article explores three penny stocks that demonstrate financial strength and potential for long-term growth, offering an intriguing opportunity for investors seeking to diversify their...

As February 2026 unfolds, the U.S. stock market is experiencing a robust start with major indices like the Dow Jones and S&P 500 posting significant gains, reflecting optimism despite recent economic uncertainties such as delayed jobs data due to a government shutdown. In this dynamic environment, identifying promising small-cap stocks requires a keen eye for companies that not only demonstrate resilience in fluctuating economic conditions but also possess unique growth potential that can...

As February 2026 begins, major U.S. stock indexes have surged, with the Dow Jones Industrial Average gaining 515 points and the S&P 500 nearing a record high, reflecting investor optimism amid recent economic developments. In this buoyant market environment, dividend stocks can offer a compelling opportunity for investors seeking steady income and potential growth, especially as companies continue to navigate evolving trade dynamics and economic policies.

Investors may be wondering whether ANI Pharmaceuticals is fairly priced at its recent levels, or if the market is overlooking something in the current share price. The stock closed at US$81.27, with returns of 2.2% over 7 days, 3.3% over 30 days, 3.6% year to date, 35.9% over 1 year, 81.2% over 3 years and 155.5% over 5 years. These figures may have some investors reassessing both upside potential and risk. Recent attention around ANI Pharmaceuticals has focused on its position within the...

StoneX Group (NasdaqGS:SNEX) has approved a three-for-two stock split aimed at broadening investor access and trading liquidity. The company also reported record quarterly revenues in its latest update. Management outlined recent acquisitions in wealth management and brokerage as part of its current expansion plans. StoneX Group operates across trading, execution, and clearing services, with a growing presence in wealth management and brokerage. For you as an investor, the combination of a...

Dow (NYSE:DOW) has launched a $1b cost-cutting program in response to a prolonged downturn in the chemicals sector. The company is reducing its workforce as part of this plan to lower operating expenses. Dow has halved its dividend, effective since last July, to preserve cash and support its balance sheet. For investors tracking NYSE:DOW, the new measures come after a mixed share price story. The stock closed at $32.4, with returns of 16.6% over the past week, 30.1% over the past month, and...

Short-seller allegations claim IonQ (NYSE:IONQ) lost key Pentagon contract funding that once accounted for a large portion of its revenue. The report links the alleged funding loss to leadership changes, including the CEO's resignation, and insider stock sales. It also highlights a series of acquisitions of non quantum businesses that, according to the report, were intended to offset the revenue gap and may have affected cash flow. IonQ has disputed these allegations, and the questions...

In recent weeks, MongoDB has drawn attention as analysts highlighted accelerating revenue growth in its Atlas cloud database business and praised its dual go-to-market approach combining enterprise sales with product-led adoption. At the same time, newly announced AI features for Atlas, including access to Voyage AI models, have reinforced perceptions that MongoDB could play a central role in AI-driven application modernization despite broader software sector concerns about artificial...

Allegion (ALLE) has put capital returns in focus after its board approved a quarterly dividend of $0.55 per share, an 8% increase from 2025. This marks the company’s 12th consecutive annual dividend raise. See our latest analysis for Allegion. Allegion’s share price has been firming up, with a 1-day share price return of 3.10% taking the stock to $173.04, a 30-day share price return of 6.89%, and a 1-year total shareholder return of 35.93% pointing to momentum that has been building rather...

InMode (NasdaqGS:INMD) confirmed it received a non binding proposal from Steel Partners Holdings L.P. to acquire a majority stake. The board has formed an independent committee to evaluate this proposal and consider a range of potential alternatives. The review process is underway and could result in a change of control or other significant outcomes for existing shareholders. InMode focuses on medical devices for aesthetic and wellness procedures, an area that sits at the intersection of...

Plains All American Pipeline (NasdaqGS:PAA) has completed its acquisition of EPIC Crude Holdings, LP. The transaction adds crude oil transport and related assets tied to long term commitments. Management expects operating synergies and integration benefits from the combined systems. Plains All American Pipeline, or PAA, operates a large network of crude oil and natural gas liquids pipelines and terminals, with a revenue mix that is largely fee based. The EPIC Crude Holdings acquisition fits...

Jacobs Solutions (J) opened fiscal Q1 2026 with revenue of about US$3.3b and basic EPS of US$1.12, setting the tone for how the year is starting after a busy 2025. The company has seen quarterly revenue move from roughly US$2.9b in Q1 2025 to US$3.3b in the latest quarter, while basic EPS shifted from a small loss of about US$0.10 to a profit of US$1.12, a swing that puts the focus firmly on how sustainable those margins prove to be. See our full analysis for Jacobs Solutions. With the...

In late January 2026, Nurix Therapeutics reported full-year 2025 revenue of US$83.98 million, up from US$54.55 million, alongside a wider net loss of US$264.46 million and an Employee Stock Ownership Plan-related shelf registration for up to 5,090,373 common shares worth about US$98.80 million. The results came as Nurix advanced its lead BTK degrader bexobrutideg into pivotal DAYBREAK development with Orphan Drug and Fast Track status, backed by partnerships with Gilead, Sanofi, and Pfizer...

Expansion in Indiana and North Carolina puts Deere (DE) in focus Deere (DE) is drawing fresh attention after outlining a $20b plan to expand U.S. manufacturing. The initiative includes a new parts distribution center in Hebron, Indiana, and an excavator factory in Kernersville, North Carolina. See our latest analysis for Deere. The expansion plan lands at a time when momentum in Deere’s shares has been picking up, with a 1 month share price return of 21.7% and a year to date share price...

McKesson (NYSE:MCK) reported strong fiscal third quarter results, highlighting continued momentum across key segments including oncology, biopharma services, and pharmaceutical distribution. The company outlined substantial progress toward separating its medical surgical business, with a planned IPO targeted by the second half of 2027. Recent acquisitions and technology investments were cited as important contributors to the period's performance and ongoing business evolution. The planned...